A Selective SARS-CoV-2 Host-Directed Antiviral Targeting Stress Response to Reactive Oxygen Species

[Image: see text] The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) catalyzed the development of vaccines and antivirals. Clinically approved drugs against SARS-CoV-2 target the virus directly, which makes them susceptible to viral mutations, which in turn can attenuate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Cong, Coelho, Ana R., Rebelo, Maria, Kiely-Collins, Hannah, Carvalho, Tânia, Bernardes, Gonçalo J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881195/
https://www.ncbi.nlm.nih.gov/pubmed/36712488
http://dx.doi.org/10.1021/acscentsci.2c01243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881195/
https://www.ncbi.nlm.nih.gov/pubmed/36712488
http://dx.doi.org/10.1021/acscentsci.2c01243

Ejemplares similares